Since 1995, four different types of artificial heart pumps and artificial valvo-pumps have been developed in Jiangsu University of China. Three types of heart pumps and valvo-pumps have been applied in animal experiments in University Texas, Medical Branch, USA and in Zhenjiang No.1 People's Hospital of China. The recently-developed UJS-IV pump is a totally implantable trans-ventricular and cross-valvular pump for emergercy treatments.
Equipment Design ; Heart Valve Prosthesis ; Heart, Artificial ; Heart-Assist Devices

Heart failure is one kind of cardiovascular disease with high risk and high incidence. As an effective treatment of heart failure, artificial heart is gradually used in clinical treatment. Blood compatibility is an important parameter or index of artificial heart, and how to evaluate it through hemodynamic design and
Heart Failure ; Heart, Artificial ; Heart-Assist Devices ; Hemodynamics ; Hemolysis ; Humans

The number of patients with heart failure in China is large, and the proportion of patients with end-stage heart failure continues to increase. The clinical effect of guideline-directed medications therapy for end-stage heart failure is poor. Heart transplantation is the most effective treatment for end-stage heart failure. But it is faced with many limitations such as the shortage of donors. In recent years, the research and development of artificial heart in China has made great progress. Three devices have been approved by the National Medical Products Administration for marketing, and another one is undergoing pre-marketing clinical trial. Since 2017, more than 200 cases of ventricular assist device implantation have been carried out in more than 34 hospitals in China. Among them, 70 patients in Fuwai Hospital, Chinese Academy of Medical Sciences had a 2-year survival rate of 90%. The first patient has survived more than 5 years with the device. More efforts should be put into the training of standardized technical team and quality control. Further research should be carried out in the aspects of pulsatile blood flow pump, fully implanted cable-free device, and improved biomaterial with better blood compatibility.
Humans ; Heart-Assist Devices ; Heart Failure/surgery* ; Heart, Artificial ; Heart Transplantation ; Pulsatile Flow

Many varieties of pulsatile blood pumps exist in the fields of artificial hearts and ventricular assist devices. Effective sorts can be achieved with the differences in power source and transmission mechanism. Horizontal comparison across different pulsatile blood pumps, together with evolution of similar species is studied to find the commonness and evolution laws for pulsatile blood pumps. After a review of typical pulsatile blood pumps from the angle of power source and transmission mechanism, much analysis is focus on a pulsatile drive structure with flexible electro-hydraulic transmission, and importance of hydraulic transmission to improve the implantation property of pulsatile blood pumps is discussed. Finally new application of electro-hydraulic pulsatile blood pumps in the future, such as the application in Direct Mechanical Ventricular Assistant Device (DMVAD) is given.
Equipment Design ; Heart, Artificial ; Heart-Assist Devices ; Pacemaker, Artificial ; Pulsatile Flow

In order to study the cardiovascular hemodynamic characteristics and evaluate the artificial heart, especially the compression cardiac assist devices, we put forward a simulating device which is made of pump, valve, tubes and controller, and can be used to imitate cardiovascular system. Moreover, in this essay, we put forth an algorithm to draw pressure-volume loop with the parameters measured, including liquid pressure, volume and air pressure. The changes in the frequency and duty of control signal and in the angle of proportional valve can symbolize cardiovascular system in different heart rates, with different systole period, and at different level, respectively. The result of simulating device experiment proved to be coincident with physiology.
Cardiovascular Physiological Phenomena ; Computer Simulation ; Equipment Design ; Heart, Artificial ; Heart-Assist Devices ; Hemodynamics ; Models, Cardiovascular

Performances of reliability and portability are important for artificial ventricular assist devices. This paper presents a remote surveillance system that can observe the condition of the patients and the driving condition of artificial heart online. The system is mainly based on the embedded Compact RIO platform and Ethernet technology. Combined with the driver module of the assist device, this remote system has been tested.
Equipment Design ; Heart, Artificial ; Heart-Assist Devices ; Remote Sensing Technology ; Robotics

Artificial heart is an effective device in solving insufficient native heart supply for heart transplant, and the research and application of novel actuators play an important role in the development of artificial heart. In this paper, artificial muscle is introduced as the actuators of direct cardiac compression assist, and some of its parameters are compared with those of native heart muscle. The open problems are also discussed.
Artificial Organs ; Assisted Circulation ; instrumentation ; Biocompatible Materials ; Equipment Design ; Heart-Assist Devices ; Humans ; Muscles

BACKGROUND AND OBJECTIVES: Ventricular assist device(VAD) was developed for the bridge to cardiac transplantation, but the current research trends proceed to the purpose of bridge to cardiac recovery. We investigated the effects of long-term VAD implantation on the hemodynamic parameters related to the prognosis of heart failure by simulation to provide the preclinical and clinical applicability. MATERIAL AND METHODS: A moving-actuator type artificial heart developed by Seoul National University Artificial Heart Laboratory was used as a model of biventricular assist device. We set initial values of hemodynamic parameters according to the guideline of VAD implantation, and performed simulation of the change of hemodynamic variables related to successful device weaning and the prognosis of heart failure. RESULTS: Cardiac indices (CIs) at 1 hour and 6 months after VAD implantation were 2.98 l/min/m2 and 2.60 l/min/m2, respectively. Systolic/diastolic/mean aorta pressure were 121/84/99 mmHg at 6 months after VAD implantation. During pump-off state at 6 month, each value of hemodynamic parameters were as follows: CI 2.53 l/min/m2, pulmonary capillary wedge pressure 10 mmHg, left ventricular end-diastolic volume 105 ml, left ventricular ejection fraction 0.58, mean aorta pressure 84 mmHg, end-systolic wall stress 108 kdyn/cm2. Peak rate of change of power(peak dPWR(t)/dt) was 5.62x108 dyneXcm/s2 after 6-month VAD implantation. In a real VAD-implanted patient, simulation data were partly compatible with real hemodynamic data, especially in the aspects of predicting VAD weaning. CONCLUSION:Long-term VAD implantation partially improved the values of hemodynamic parameters related to the prognosis, and this simulation results will provide the basic concept and applicability of clinical trial for end-stage heart failure.
Aorta ; Heart Failure* ; Heart Transplantation ; Heart* ; Heart, Artificial ; Heart-Assist Devices ; Hemodynamics* ; Humans ; Prognosis ; Pulmonary Wedge Pressure ; Seoul ; Stroke Volume ; Weaning

BACKGROUND: It has been shown that low-grade electrical stimulus can transform fatigue resistant muscles which then can be used to protect the heart. The bulky and cumbersome power sources of the artificial heart or implantable ventricular assist devices are still in need of solution; however, on the other hand, the implantable ventricular assist devices using the resistant muscles as the power source have the advantages of using its own muscle contractions. The purpose of this study was to determine the possibility of a clinical application of the skeletal muscle ventricle. MATERIAL AND METHOD: Latissimus dorsi muscles (LDM) of 8 canines were used for skeletal muscle ventricle. A latex chamber was wrapped one and a half times with LDM. The chamber was attached to a pressure transducer via Tygon tube. An electrode stimulator was placed around the thoracodorsal nerve and LDM was stimulated in cyclic bursts of 0.31 sec on time and 6.0 sec off time using 3.0 volt Itrel stimulator. The preload volume was added to the system in 25cc increments. Ejection volumes, pressures, and peak power outputs were measured. RESULT: Ejection volume was 76.3cc with 0cc of preload. Ejection volumes were less than 70ml with increments of preload over 75cc Pressures were more than 107 mmHg when the preloads were less than 75cc and less than 100 mmHg when the preloads were more than 100cc. Peak power output of 16.6 W/kg was observed at 50cc preload. CONCLUSION: Depending on the changes of preload, the volumes ejected from skeletal muscle ventricle and pressures from the skeletal muscle contraction surpassed those of the normal heart. These data suggest that there are clinical applications for skeletal muscle ventricular assist system.
Electric Power Supplies ; Electrodes ; Fatigue ; Hand ; Heart ; Heart Ventricles ; Heart, Artificial ; Heart-Assist Devices ; Latex ; Muscle Contraction ; Muscle, Skeletal* ; Muscles ; Skeletal Muscle Ventricle* ; Superficial Back Muscles ; Transducers, Pressure

No abstract available.
Heart, Artificial*